文献速递临床免疫质量管理与危急值

新型化学发光ST2检测的分析性能评估与参考限建立

Analytical performance evaluation and reference limits establishment of a new chemiluminescence growth stimulation expressed Gene 2 Assay.
PubMed 文献 · Clin Chim Acta · 2026-01-22

本研究依据CLSI指南验证了迈瑞ST2化学发光免疫分析(CLIA)的精密度、检测能力、线性、干扰和样本类型相关性,并与Presage ST2 ELISA比对;基于1592名健康成人建立了性别特异性99百分位参考上限。结果显示该检测精密度高、线性好、干扰小,男性、女性和总体99百分位URL分别为42.3、36.2和37.7 ng/mL。

要点

  • ST2 CLIA检测 repeatability和reproducibility CV均<5%。
  • 线性范围2.00–2000 ng/mL(r>0.99),样本类型间相关性r>0.99。
  • 男性99百分位URL 42.3 ng/mL,女性36.2 ng/mL,总体37.7 ng/mL。

核心结论

  • 迈瑞ST2化学发光免疫分析具有稳健的分析性能,高精密度、灵敏度和特异性满足临床需求。
  • 建立的性别特异性参考区间支持其用于精准患者分层。

研究设计与样本

  • 依据CLSI指南验证精密度、检测能力、线性、干扰和样本类型相关性。
  • 与Presage ST2 ELISA(Critical Diagnostics)进行方法比对。
  • 从1592名健康成人建立性别特异性99百分位参考上限。

主要发现

  • 重复性和重现性CV均<5%。
  • 空白限、检出限和定量限均在声称规格内。
  • 2.00至2000 ng/mL范围内线性极佳(r>0.99)。
  • 未观察到显著干扰,不同样本类型间相关性高(r>0.99)。
  • 与Presage ST2 assay比对回归方程为y = 1.0365x - 1.9307(r = 0.9760)。

关键数值与推荐

  • 99百分位URL:男性42.3 ng/mL,女性36.2 ng/mL,总体37.7 ng/mL。

临床怎么用

  • 该ST2 CLIA检测可用于临床评估心肌纤维化和心室重构。
  • 性别特异性参考上限有助于患者风险分层。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: Growth stimulation expressed gene 2 (ST2) is an established biomarker for assessing myocardial fibrosis and ventricular remodeling in heart disease. This study aimed to comprehensively evaluate the analytical performance of a novel chemiluminescent immunoassay (CLIA) for ST2 and to establish its reference limits. METHODS: Analytical performance, including precision, detection capability, linearity, interference, and sample type correlation, was validated according to CLSI guidelines. A method comparison was conducted with the Presage ST2 ELISA (Critical Diagnostics). Sex-specific 99th percentile upper reference limits (URLs) were established from 1592 healthy adults. RESULTS: The ST2 (CLIA) assay demonstrated high precision, with both repeatability and reproducibility CVs < 5%. The limits of blank (LoB), detection (LoD), and quantitation (LoQ) were within the claimed specifications. The assay showed excellent linearity from 2.00 to 2000 ng/mL (r > 0.99). No significant interference was observed, and correlations between different sample types were high (r > 0.99). Method comparison with the Presage ST2 assay yielded a regression equation of y = 1.0365x - 1.9307 (r = 0.9760). The 99th percentile URLs were 42.3 ng/mL for males, 36.2 ng/mL for females, and 37.7 ng/mL for the overall cohort. CONCLUSIONS: The Mindray ST2 chemiluminescent immunoassay exhibits robust analytical performance, meeting the demands of clinical practice with high precision, sensitivity, and specificity. The established reference intervals support its application for precise patient stratification.

来源:Clin Chim Acta,查看原文。版权归原作者所有。

引用

  1. Zhang L, Zhang C, Shu X, et al. Analytical performance evaluation and reference limits establishment of a new chemiluminescence growth stimulation expressed Gene 2 Assay. Clin Chim Acta. 2026. PMID: 41580064. doi:10.1016/j.cca.2026.120850

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。